1. Objective:To explore the treatment of pure red cell aplasia(PRCA)after ABO-incompatible allogeneic peripheral blood stem cell transplantation.

2. Objective To study pure red cell aplasia(PRCA) of complication after ABO- incompatible allogeneic stem cell transplantation.

3. Similarly, a variety of chemotherapeutic alkylating agents produce aplasia and pose a risk to workers responsible for producing or administering these compounds.

4. Objective: Chronic aplasia is common in clinic after renal transplantation, maybe 39% of the recipients.

5. As shown in published literatures, aplasia cutis congenita (ACC) is an uncommon anomaly among newborns and is often overlooked when the lesion is small.

6. Objective To review the clinical and laboratory features of the reported patients with systemic lupus erythematosus (SLE) and pure red cell aplasia (PRCA).

7. Decreased production of platelets in the marrow may be caused by drugs, toxins, or by primary marrow disorders such as aplasia, fibrosis, or hematopoietic malignancy.

8. Methods The red cell antibodies were removed by DFPP in 5 recipients to prevent hemolysis and pure red cell aplasia following major ABO-incompatible unrelated bone marrow transplantation.

9. The prognosis is good and no recurrence occurs, The disease may be differentiated from congenital pure red cell aplasia by its relatively late onset and good prognosis.

10. Objective To discuss how to diagnose and treat thymoma associated with pure red cell aplasia (PRCA).

11. We report this case and also review the literature, and then we suggest a checklist for aplasia cutis congenita.

12. Objective: To explore the clinical features of thymoma associated with pure red cell aplasia and to evaluate outcome of surgical treatment.

13. RESULTS: One out of fourteen recipients developed pure red cell aplasia and dropped out of final analysis.

14. Mamiya S, hoh T,[http://] Miura AB. Acquired pure red cell aplasia in.

15. Objective : To investigate the diagnosis, etiology, pathogenesis and therapy of pure red cell aplasia ( PRCA ).

16. Objective:To explore the diagnosis and treatment of thymoma with pure red cell aplasia(PRCA).

17. Acute radiation injury as well as radiotherapy and chemotherapy of tumor can lead to different extents of bone marrow aplasia .

18. Objective To evaluate the inoact of low immune function and the pure red cell aplasia (PRCA) in patients with simultaneous pancreas-kidney transplantation.

19. Conclusion DFPP can effectively prevent hemolysis and pure red cell aplasia in recipients of unrelated bone marrow transplantation with major ABO- incompatibility .